← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 30, 2021Last known activity
Oct 20, 2021
Acquired by Caladrius Biosciences on Apr 27, 2022
Timeline
2010s
- Jun 1, 2015
Cend Therapeutics Inc.— Founded
2020s
- Apr 27, 2022
Caladrius Biosciences— Acquired By
Drugs by trial phase (3 distinct, 2 trials)
Phase 2 (3 own, 0 via acquisition)
Recent trials (2)
- NCT05121038CollaboratorPhase 1/Phase 2Oct 20, 2021
- NCT05052567CollaboratorPhase 1/Phase 2Sep 30, 2021
Details
- Founded
- San Diego, CA, US Jun 1, 2015
- Last known activity
- Oct 20, 2021